Pfizer Limited

PFIZER.NS·NSE·Healthcare
Compare
3,856.90+22.20 (+0.58%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3,834.70
Open3,903.90
Day range3,835.003,904.70
52-week range3,589.005,339.00
Off day high−1.22%
Off 52-week high−27.76%
Volume23.02K
Avg. volume (3M)53.47K
Market cap176.44B
EPS (TTM)166.49
Forward P/E18.83
P/E ratio (TTM)23.17
Dividend yield1.96% (75.00)
Beta (5Y)0.16
Shares outstanding45.75M
Short interest—
Earnings dateNov 3, 2026
Analyst target6,008.50
Profit margin32.38%

Against its peers

Compare in full ›
PFIZER.NS AZN SANOFI.NS MRK GLAXO.BO SNY
Market cap 176.44B 293.14B 78.12B 370.96B 423.63B 113.74B
P/E (TTM) 23.2 26.7 21.4 151.9 44.4 23.6
Forward P/E 18.8 16.7 19.1 16.7 36.9 8.9
Price/book 4.0 5.7 9.5 8.9 24.8 1.4
Dividend yield 1.96% 1.69% 3.56% 2.26% 1.75% 5.10%
1-year change −24.33% +12.81% −28.75% +75.29% +6.17% −4.08%
Today +0.58% +2.79% −1.70% +3.93% −1.26% +4.72%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

The Globe and Mail·Positive

Pfizer (PFE) Gets a Hold from J.P. Morgan

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer today and set a price target of $30.00. Schott covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Pfizer. According to TipRanks,…

Moneycontrol·Positive

Buy Pfizer; target of Rs 4800: ICICI Securities

Moneycontrol.com Buy Pfizer; target of Rs 4800: ICICI Securities ICICI Securities's research report on Pfizer Pfizer delivered a revenue beat in Q2FY27, though EBITDA and PAT were in line with our expectations. Revenue advanced ~13.2%…

The Motley Fool·Positive

Pfizer: 3 Key Takeaways for Long-Term Investors

The patent-expiry question is still open: whether cutting costs now buys enough time for late-stage trials to replace fading blockbuster revenue. New treatments and recent acquisitions are generating immediate sales growth that buffers…

MarketScreener·Negative

Pfizer Inc. : UBS sticks Neutral

www.marketscreener.com Pfizer Inc. : UBS sticks Neutral Published on 11/04/2026 at 10:01 am EST Latest news about Pfizer Inc. Income Statement and Estimates Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC May 05, 2026 at 05:57 pm EDT…

From the 4Search news index, newest first.

In the news

253mentions in 30 days
253with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance